Effects of oral HPΒCD-angiotensin-(1-7) supplementation on recreational mountain bike athletes: a crossover study.

BACKGROUND: Supplementation with Angiotensin-(1-7) [(Ang-1-7)] has received considerable attention due to its possible ergogenic effects on physical performance. The effects of a single dose of Ang-(1-7) on the performance of mountain bike (MTB) athletes during progressive load tests performed until the onset of voluntary fatigue have previously been demonstrated. This study tested the effects of Ang-(1-7) in two different exercise protocols with different metabolic demands: aerobic (time trial) and anaerobic (repeated sprint). METHODS: Twenty one male recreational athletes were given capsules containing an oral formulation of HPßCD-Ang-(1-7) (0.8 mg) and HPßCD-placebo (only HPßCD) over a 7-day interval; a double-blind randomized crossover design was used. Physical performance was examined using two protocols: a 20-km cycling time trial or 4 × 30-s repeated all-out sprints on a leg cycle ergometer. Data were collected before and after physical tests to assess fatigue parameters, and included lactate levels, and muscle activation during the sprint protocol as evaluated by electromyography (EMG); cardiovascular parameters: diastolic and systolic blood pressure and heart rate; and performance parameters, time to complete (time trial), maximum power and mean power (repeated sprint). RESULTS: Supplementation with an oral formulation of HPßCD-Ang-(1-7) reduced basal plasma lactate levels and promoted the maintenance of plasma glucose levels after repeated sprints. Supplementation with HPßCD-Ang-(1-7) also increased baseline plasma nitrite levels and reduced resting diastolic blood pressure in a time trial protocol. HPßCD-Ang-(1-7) had no effect on the time trial or repeat sprint performance, or on the EMG recordings of the vastus lateralis and vastus medialis. CONCLUSIONS: Supplementation with HPßCD-Ang-(1-7) did not improve physical performance in time trial or in repeated sprints; however, it promoted the maintenance of plasma glucose and lactate levels after the sprint protocol and at rest, respectively. In addition, HPßCD-Ang-(1-7) also increased resting plasma nitrite levels and reduced diastolic blood pressure in the time trial protocol. TRIAL REGISTRATION: RBR-2nbmpbc, registered January 6th, 2023. The study was prospectively registered.

The Effect of Low-intensity Aerobic Training Combined with Blood Flow Restriction on Maximal Strength, Muscle Mass, and Cycling Performance in a Cyclist with Knee Displacement.

Low-intensity aerobic training combined with blood flow restriction (LI + BFR) has resulted in increases in aerobic and neuromuscular capacities in untrained individuals. This strategy may help cyclists incapable of training with high intensity bouts or during a rehabilitation program. However, there is a lack of evidence about the use of LI + BFR in injured trained cyclists. Thus, we investigated the effects of LI + BFR on aerobic capacity, maximal isometric strength, cross-sectional area of vastus lateralis (CSAVL), time to exhaustion test (TTE), and 20 km cycling time-trial performance (TT20 km) in a male cyclist with knee osteoarthritis (OA). After a 4-week control period, a 9-week (2 days/week) intervention period started. Pre- and post-intervention TT20 km, peak oxygen consumption (VO2peak), power output of the 1st and 2nd ventilatory thresholds (1st WVT and 2nd WVT), maximum power output (Wmax), TTE, muscle strength and CSAVL of both legs were measured. Training intensity was fixed at 30% of Wmax while the duration was progressively increased from 12 min to 24 min. There was a reduction in time to complete TT20 km (-1%) with increases in TT20 km mean power output (3.9%), VO2peak (11.4%), 2nd WVT (8.3%), Wmax (3.8%), TTE (15.5%), right and left legs maximal strength (1.3% and 8.5%, respectively) and CSAVL (3.3% and 3.7%, respectively). There was no alteration in 1st WVT. Based on the results, we suggest that LI + BFR may be a promising training strategy to improve the performance of knee-injured cyclists with knee OA.

Beta-alanine did not improve high-intensity performance throughout simulated road cycling.

This study investigated the effect of beta-alanine supplementation on short-duration sprints and final 4-km simulated uphill cycling time-trial performance during a comprehensive and novel exercise protocol representative of the demands of road-race cycling, and determined if changes were related to increases in muscle carnosine content. Seventeen cyclists (age 38 ± 9 y, height 1.76 ± 0.07 m, body mass 71.4 ± 8.8 kg, V̇O2max 52.4 ± 8.3 ml·kg-1·min-1) participated in this placebo-controlled, double-blind study. Cyclists undertook a prolonged intermittent cycling protocol lasting 125 min, with a 10-s sprint every 20 min, finishing with a 4-km time-trial at 5% simulated incline. Participants completed two familiarization sessions, and two main sessions, one pre-supplementation and one post-supplementation following 28 days of 6.4 g·day-1 of beta-alanine (N=11) or placebo (N=6; maltodextrin). Muscle biopsies obtained pre- and post-supplementation were analysed for muscle carnosine content. There were no main effects on sprint performance throughout the intermittent cycling test (all P>0.05). There was no group (P=0.69), time (P=0.50) or group x time interaction (P=0.26) on time-to-complete the 4-km time-trial. Time-to-completion did not change from pre- to post-supplementation for BA (-19.2 ± 45.6 s, P=0.43) or PL (+2.8 ± 31.6 s, P=0.99). Beta-alanine supplementation increased muscle carnosine content from pre- to post-supplementation (+9.4 ± 4.0 mmol·kg-1dm; P<0.0001) but was not related to performance changes (r=0.320, P=0.37). Chronic beta-alanine supplementation increased muscle carnosine content but did not improve short-duration sprint performance throughout simulated road race cycling, nor 4-km uphill time-trial performance conducted at the end of this cycling test.HighlightsPerformance during prolonged cycling events often depends on the ability to maintain an increased power output during higher intensity periods. Thus, cyclists are likely heavily dependent on their ability to resist fatigue during these periods of high-intensity activity.Meta-analytical data show beta-alanine to be an effective supplement to improve exercise outcomes, but little work exists on its efficacy during dynamic actions that are common during prolonged cycling.Beta-alanine supplementation increased muscle carnosine content but did not generate improvements in the performance of high-intensity cycling (10-s sprints or 4-km uphill time-trial) during a simulated road race cycling protocol.These data suggest that short duration sprints (≤10 s) and longer duration (>10 min) high-intensity activity throughout endurance cycling may not be improved with beta-alanine supplementation despite increases in muscle carnosine content.

Footwear designed to enhance energy return improves running economy compared to a minimalist footwear: does it matter for running performance?

The present study compared the effects of a footwear designed to enhance energy return (thermoplastic polyurethane, TPU) vs minimalist shoes on running economy (RE) and endurance performance. In this counterbalanced and crossover design study, 11 recreational male runners performed two submaximal constant-speed running tests and two 3-km time-trials with the two shoe models. Oxygen uptake was measured during submaximal constant-speed running tests in order to determine the RE at 12 km/h and oxygen cost of running (CTO2) at individual average speed sustained during the 3-km running time-trials wearing either of the two shoes. Our results revealed that RE was improved (2.4%) with TPU shoes compared with minimalist shoes (P=0.01). However, there was no significant difference for CTO2 (P=0.61) and running performance (P=0.52) comparing the TPU (710±60 s) and the minimalist (718±63 s) shoe models. These novel findings demonstrate that shoes with enhanced mechanical energy return (i.e. TPU) produced a lower energy cost of running at low (i.e., 12 km/h) but not at high speeds (i.e., average speed sustained during the 3-km running time-trial, ∼15 km/h), ultimately resulting in similar running performance compared to the minimalist shoe.

Acute Caffeinated Coffee Consumption Does not Improve Time Trial Performance in an 800-m Run: A Randomized, Double-Blind, Crossover, Placebo-Controlled Study.

INTRODUCTION: Studies evaluating caffeinated coffee (CAF) can reveal ergogenic effects; however, studies on the effects of caffeinated coffee on running are scarce and controversial. AIM: To investigate the effects of CAF consumption compared to decaffeinated coffee (DEC) consumption on time trial performances in an 800-m run in overnight-fasting runners. METHODS: A randomly counterbalanced, double-blind, crossover, placebo-controlled study was conducted with 12 healthy adult males with experience in amateur endurance running. Participants conducted two trials on two different occasions, one day with either CAF or DEC, with a one-week washout. After arriving at the data collection site, participants consumed the soluble CAF (5.5 mg/kg of caffeine) or DEC and after 60 min the run was started. Before and after the 800-m race, blood pressure and lactate and glucose concentrations were measured. At the end of the run, the ratings of perceived exertion (RPE) scale was applied. RESULTS: The runners were light consumers of habitual caffeine, with an average ingestion of 91.3 mg (range 6⁻420 mg/day). Time trial performances did not change between trials (DEF: 2.38 + 0.10 vs. CAF: 2.39 + 0.09 min, p = 0.336), nor did the RPE (DEC: 16.5 + 2.68 vs. CAF: 17.0 + 2.66, p = 0.326). No difference between the trials was observed for glucose and lactate concentrations, or for systolic and diastolic blood pressure levels. CONCLUSION: CAF consumption failed to enhance the time trial performance of an 800-m run in overnight-fasting runners, when compared with DEC ingestion. In addition, no change was found in RPE, blood pressure levels, or blood glucose and lactate concentrations between the two trials.

Dispelling the myth that habitual caffeine consumption influences the performance response to acute caffeine supplementation.

This study investigates the influence of habitual caffeine intake on aerobic exercise-performance responses to acute caffeine supplementation. A double-blind, crossover, counterbalanced study was performed. Forty male endurance-trained cyclists were allocated into tertiles, according to their daily caffeine intake: low (58 ± 29 mg/d), moderate (143 ± 25 mg/d), and high (351 ± 139 mg/d) consumers. Participants completed three trials in which they performed simulated cycling time trials (TTs) in the fastest time possible following ingestion of the following: caffeine (CAF: 6 mg/kg body mass), placebo (PLA), and no supplement (CON). A mixed-model analysis revealed that TT performance was significantly improved in CAF compared with PLA and CON (29.92 ± 2.18 vs. 30.81 ± 2.67 and 31.14 ± 2.71 min, respectively; P = 0.0002). Analysis of covariance revealed no influence of habitual caffeine intake as a covariate on exercise performance (P = 0.47). TT performance was not significantly different among tertiles (P = 0.75). No correlation was observed between habitual caffeine intake and absolute changes (CAF - CON) in TT performance with caffeine (P = 0.524). Individual analysis showed that eight, seven, and five individuals improved above the variation of the test in CAF in the low, moderate, and high tertiles, respectively. A Fisher's exact test did not show any significant differences in the number of individuals who improved in CAF among the tertiles (P > 0.05). Blood lactate and ratings of perceived exertion were not different between trials and tertiles (P > 0.05). Performance effects of acute caffeine supplementation during an ~30-min cycling TT performance were not influenced by the level of habitual caffeine consumption.NEW & NOTEWORTHY There has been a long-standing paradigm that habitual caffeine intake may influence the ergogenicity of caffeine supplementation. Low, moderate, and high caffeine consumers showed similar absolute and relative improvements in cycling time-trial performance following acute supplementation of 6 mg/kg body mass caffeine. Performance effects of acute caffeine were not influenced by the level of habitual caffeine consumption, suggesting that high habitual caffeine intake does not negate the benefits of acute caffeine supplementation.

The effects of block training on pacing during 20-km cycling time trial.

The aim of this study was to determine the effects of block training (BL) on pacing during a 20-km hilly cycling time trial (TT) in trained cyclists. Twenty male cyclists were separated into 2 groups: control and BL. The training of each cyclist was monitored during a period of 3 weeks. In the first week cyclists performed an overload period of 7 consecutive days of high-intensity interval training followed by 2 weeks of normal training. Cyclists performed 1 TT before intervention and 2 TT after 7 and 14 days at the end of training. Each training session consisted of 10 sets of 3 repeated maximal-effort sprints (15, 30, and 45 s) with an effort/recovery duration ratio of 1:5. The main finding of this study was that the power output displayed a significantly higher start from the start until the halfway point of the TT (p < 0.05). Additionally, power output was characterized by a significant higher end spurt in the final 2 km in the BL after 2 weeks at the end of training (p < 0.05). In addition, after 2 weeks at the end of the overload period the distribution of cadence was significantly lower throughout the TT (p < 0.01). Therefore, a short period of consecutive days of intense training enhances cycling performance and changes the power output in the beginning and final part of the TT in trained cyclists.

Placebo in sports nutrition: a proof-of-principle study involving caffeine supplementation.

We investigated the effects of supplement identification on exercise performance with caffeine supplementation. Forty-two trained cyclists (age 37 ± 8 years, body mass [BM] 74.3 ± 8.4 kg, height 1.76 ± 0.06 m, maximum oxygen uptake 50.0 ± 6.8 mL/kg/min) performed a ~30 min cycling time-trial 1 h following either 6 mg/kgBM caffeine (CAF) or placebo (PLA) supplementation and one control (CON) session without supplementation. Participants identified which supplement they believed they had ingested ("caffeine", "placebo", "don't know") pre- and post-exercise. Subsequently, participants were allocated to subgroups for analysis according to their identifications. Overall and subgroup analyses were performed using mixed-model and magnitude-based inference analyses. Caffeine improved performance vs PLA and CON (P ≤ 0.001). Correct pre- and post-exercise identification of caffeine in CAF improved exercise performance (+4.8 and +6.5%) vs CON, with slightly greater relative increases than the overall effect of caffeine (+4.1%). Performance was not different between PLA and CON within subgroups (all P > 0.05), although there was a tendency toward improved performance when participants believed they had ingested caffeine post-exercise (P = 0.06; 87% likely beneficial). Participants who correctly identified placebo in PLA showed possible harmful effects on performance compared to CON. Supplement identification appeared to influence exercise outcome and may be a source of bias in sports nutrition.

Influência do aprendizado e da informação espaço-tempo no desempenho de corredores em testes contrarrelógio / Influence of learning and space-time feedback on the time trial performance of amateur runners

O teste contrarrelógio (TCR), ou teste de resistência com término previamente estabelecido pelas dimensões tempo ou distância, é utilizado como meio de avaliação do desempenho de corredores em uma situação com variação livre da velocidade.Tanto o aprendizado motor, isto é, a transição de uma situação nova para rotina,quanto o processamento de informações dimensionais, são aspectos cognitivos que podem influenciar o resultado do TCR. Portanto, procurou-se avaliar a influência da informação dimensional exclusiva do tempo transcorrido ou da distância percorrida na reprodutibilidade do desempenho (i.e. tempo total) entre dois TCRs em situação novidade. Adicionalmente, a estratégia decorrida de um TCR-rotina foi comparada ao TCR-novidade para avaliar a influência do aprendizado no desempenho. Para este fim, seis corredores amadores realizaram dois TCRs de 3000m (T3000)com 15 dias de intervalo como linha de base. O T3000 fazia parte da rotina dos últimos três anos de treinamento. Ao longo dos 15 dias, foram realizados duas duplicatas de TCRs-novidade com intervalos de 48h entre as repetições. Os TCRs-novidade duplicados foram testes repetidos em distâncias idênticas não vivenciadas previamente. Na duplicata 1, os corredores tiveram informação do tempo transcorrido e, na duplicata 2, da distância percorrida.Todos os corredores utilizaram aparelho GPS. Observou-se que a informação exclusiva da distância ou do tempo não influenciou a reprodutibilidade do desempenho do TCR-novidade.Contudo, os corredores apresentaram uma estratégia de corrida em “W”, com maior velocidade média,reproduzida apenas nos testes T3000-rotina. Portanto, os corredores apresentaram uma estratégia decorrida mais eficiente e específica no T3000-rotina que não foi reproduzida em distâncias similares em situação novidade. Aponta para o desenvolvimento de métodos de treinamento de corrida que aprimorem a transição da habilidade apresentada na rotina de treinamento para uma situação de novidade...

The time trial (TT) test, previously set by time or distance, is used to evaluate theperformance in a situation where power or speed is freely changed by the athlete. The motor learning,namely the transition between novelty to routine, and the processing of dimensional information mayinfluence the pacing strategy and time trial performance. Therefore, our purpose was to evaluate theinfluence of elapsed time or distance covered feedback on the reproducibility of performance (i.e. totaltime) comparing two TTs in novelty, that is, with dimensions never experienced before. In addition, thepacing of a TT in routine, that is, with dimension experienced several times, was compared with the TT innovelty to assess the influence of learning on performance. Six amateur runners performed two 3000m TT(3000TT) within fifteen days as baseline. The 3000TT was the test of routine for the last three years ofrunning training. Along the 15 days, two TT in novelty with different dimensions were duplicated with48h between each trial. Along the TT in novelty, runners had the feedback of elapsed time (duplicate 1) ordistance covered (duplicate 2), exclusively. All runners used a GPS device during the trials. We found thatexclusive information of elapsed time or distance covered did not influence the time trial’s reproducibility.Nevertheless, the runners showed a “W-shape” pacing, with the highest average speed only reproducedwithin the two 3000TT routine tests. Therefore, the runners showed a more efficient and specific pacingstrategy during the TT in routine which was not reproduced during the TTs in novelty with similardimensions. Our study highlights the importance of training methods that transpose the performance of aroutine ability to novel contexts...

Variáveis fisiológicas e neuromusculares associadas com a performance aeróbia em corredores de endurance: efeitos da distância da prova / Physiological and neuromuscular variables associated to aerobic performance in endurance runners: effects of the event distance

O objetivo deste estudo foi analisar a validade do consumo máximo de oxigênio (VO2max), velocidade associada ao VO2max (vVO2max), tempo de exaustão na vVO2max (Tlim), limiar anaeróbio (LAn), economia de corrida (EC) e força explosiva (FE) para predizer a performance aeróbia de corredores de endurance nas distâncias de 1.500m, 5.000m e 10.000m. Participaram deste estudo 11 corredores de endurance moderadamente treinados (28,36 ± 6,47 anos) que realizaram os seguintes testes: provas simuladas em uma pista de 400m em diferentes dias, nas distâncias de 10.000m, 5.000m e 1.500m; teste incremental máximo para determinar os índices VO2max, vVO2max, e LAn; um teste submáximo de carga constante para determinar a EC, seguido por um teste máximo também de carga constante a 100 por cento da vVO2max para determinar o Tlim; e um teste de salto vertical para determinar a FE. De acordo com a análise de regressão múltipla, a vVO2max utilizada de forma isolada explicou 57 por cento da variação de performance na prova de 1.500m. No entanto, quando o Tlim, a FE e a vVO2max foram analisados em conjunto, a explicação para a performance nessa prova foi de 88 por cento. Nos 5.000m, o Tlim, a vVO2max e o LAn responderam por 88 por cento da variação de performance (p < 0,05). Diferentemente, na prova de 10.000m, o LAn foi a única variável que apresentou capacidade de predição de performance. Em conclusão, a predição da performance aeróbia de corredores moderadamente treinados por meio de variáveis fisiológicas e neuromusculares é dependente da distância da prova (1.500m, 5.000m e 10.000m).

The objective of this study was to analyze the validity of maximal oxygen uptake (VO2max), velocity corresponding to the maximal oxygen uptake (vVO2max), time to exhaustion in the vVO2max (Texh), anaerobic threshold (AT), running economy (RE), and explosive strength (ES) to predict performance in 1.500m, 5,000m, and 10,000m running events. Eleven moderately trained endurance runners (28.36 ± 6.47 years) participated in this study and performed: 10.000m, 5.000m, and 1.500m time trials on a 400m track; a maximal incremental load test to determine the VO2max, vVO2max, and AT; a submaximal and maximal constant load test to determine RE and Texh, respectively; and a vertical jump test to determine ES. The vVO2max alone accounted for 57 percent of variance in the 1.500m running performance. However, when the Texh, ES, and vVO2max were analyzed together, they were able to explain 88 percent of the performance. In the 5.000m running trial, Texh, vVO2max, and vAT responded for 88 percent of the performance (p<0.05). Differently, in the 10.000m time trial, the vAT was the only variable able to predict performance. In conclusion, the prediction of aerobic running performance based on VO2max, vVO2max, Texh, AT, RE, and ES is dependent on the running distance (1.500m, 5.000m, and 10.000m).